Shawver Laura
Insider CIK 1551891 · CRTX Director · THOR President and CEO, Director · SBTX Chief Executive Officer, Director · NKTX Director · RLAY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-08 | 27,493 | — | $0 | 24,062 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-08 | 22,509 | — | $0 | 51,555 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-04-07 | 2025-04-08 | 50,002 | $12.30 | $615.0K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-04-07 | 2025-04-08 | 27,493 | $4.85 | $133.3K | 260,348 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-04-07 | 2025-04-08 | 22,509 | $4.85 | $109.2K | 232,855 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-03-06 | 2025-03-07 | 49,600 | — | $0 | 74,064 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-03-06 | 2025-03-07 | 49,600 | $4.85 | $240.6K | 259,946 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-03-06 | 2025-03-07 | 49,600 | $11.21 | $556.0K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-03-05 | 2025-03-07 | 400 | — | $0 | 123,664 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 400 | $11.00 | $4.4K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-03-05 | 2025-03-07 | 400 | $4.85 | $1.9K | 210,746 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-02-03 | 2025-02-04 | 9,064 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-02-03 | 2025-02-04 | 40,936 | — | $0 | 124,064 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-02-03 | 2025-02-04 | 9,064 | $3.15 | $28.6K | 219,410 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 50,000 | $12.31 | $615.5K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-02-03 | 2025-02-04 | 40,936 | $4.85 | $198.5K | 260,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-06 | 2025-01-07 | 50,000 | — | $0 | 9,064 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 50,000 | $11.10 | $555.0K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-01-06 | 2025-01-07 | 50,000 | $3.15 | $157.5K | 260,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-04 | 2024-12-04 | 14,772 | — | $0 | 59,064 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-04 | 2024-12-04 | 14,772 | $3.15 | $46.5K | 225,118 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-04 | 2024-12-04 | 14,772 | $13.75 | $203.1K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-03 | 2024-12-04 | 25,606 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-03 | 2024-12-04 | 62,378 | — | $0 | 73,836 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-03 | 2024-12-04 | 87,984 | $13.26 | $1.17M | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-03 | 2024-12-04 | 62,378 | $3.15 | $196.5K | 298,330 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-03 | 2024-12-04 | 25,606 | $1.27 | $32.5K | 235,952 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 29,628 | — | $0 | 25,606 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 67,616 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 29,628 | $1.27 | $37.6K | 307,590 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 901 | $14.34 | $12.9K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 96,343 | $13.55 | $1.31M | 211,247 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 67,616 | $1.27 | $85.9K | 277,962 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2024-06-03 | 2024-06-05 | 102,225 | — | $0 | 102,225 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-05 | 2,997 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-05 | 97,003 | — | $0 | 55,235 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-09-01 | 2023-09-05 | 2,997 | $1.27 | $3.8K | 213,343 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-09-01 | 2023-09-05 | 100,000 | $7.71 | $771.0K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-09-01 | 2023-09-05 | 97,003 | $1.27 | $123.2K | 310,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-08-04 | 2023-08-07 | 18,897 | — | $0 | 2,997 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-08-04 | 2023-08-07 | 18,897 | $7.06 | $133.4K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-08-04 | 2023-08-07 | 18,897 | $1.27 | $24.0K | 229,243 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-08-03 | 2023-08-07 | 26,017 | — | $0 | 21,894 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-08-03 | 2023-08-07 | 26,107 | $1.27 | $33.2K | 236,453 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-08-03 | 2023-08-07 | 26,107 | $7.01 | $183.0K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-08-02 | 2023-08-03 | 36,281 | — | $0 | 48,001 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-08-02 | 2023-08-03 | 36,281 | $7.09 | $257.2K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-08-02 | 2023-08-03 | 36,281 | $1.27 | $46.1K | 246,627 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-08-01 | 2023-08-03 | 18,715 | — | $0 | 84,282 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-08-01 | 2023-08-03 | 18,715 | $1.27 | $23.8K | 229,061 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-08-01 | 2023-08-03 | 18,715 | $7.19 | $134.6K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-07-07 | 2023-07-07 | 8,858 | — | $0 | 102,997 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-07-07 | 2023-07-07 | 8,858 | $1.27 | $11.2K | 219,204 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-07-07 | 2023-07-07 | 8,858 | $6.36 | $56.3K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-07-06 | 2023-07-06 | 33,510 | — | $0 | 111,855 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-07-06 | 2023-07-06 | 33,510 | $6.34 | $212.5K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-07-06 | 2023-07-06 | 33,510 | $1.27 | $42.6K | 243,856 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-07-05 | 2023-07-06 | 31,112 | — | $0 | 145,365 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-07-05 | 2023-07-06 | 31,112 | $1.27 | $39.5K | 241,458 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-07-05 | 2023-07-06 | 31,112 | $6.41 | $199.4K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-07-03 | 2023-07-06 | 26,520 | — | $0 | 176,477 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-07-03 | 2023-07-06 | 26,520 | $1.27 | $33.7K | 236,866 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-07-03 | 2023-07-06 | 26,520 | $6.73 | $178.5K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-06-27 | 2023-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-02 | 26,941 | — | $0 | 202,997 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-06-02 | 2023-06-02 | 26,941 | $6.95 | $187.2K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-06-02 | 2023-06-02 | 26,941 | $1.27 | $34.2K | 237,287 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-06-01 | 2023-06-02 | 73,059 | — | $0 | 229,938 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-06-01 | 2023-06-02 | 73,059 | $1.27 | $92.8K | 283,405 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-06-01 | 2023-06-02 | 73,059 | $6.80 | $496.8K | 210,346 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2023-05-31 | 2023-06-01 | 66,055 | — | $0 | 66,055 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | G Gift | 2023-05-24 | 2023-05-26 | 12,099 | — | $0 | 40,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-05-09 | 2023-05-10 | 42,900 | — | $0 | 302,997 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-05-09 | 2023-05-10 | 42,900 | $5.31 | $227.8K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-05-09 | 2023-05-10 | 42,900 | $1.27 | $54.5K | 253,246 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2023-05-08 | 2023-05-10 | 57,100 | — | $0 | 345,897 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2023-05-08 | 2023-05-10 | 57,100 | $1.27 | $72.5K | 267,446 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2023-05-08 | 2023-05-10 | 57,100 | $6.16 | $351.7K | 210,346 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2022-11-09 | 2023-05-10 | 43,896 | $4.58 | $201.0K | 210,346 | SEC↗ |
| SBTX Silverback Therapeutics, I | M Exercise deriv | 2022-08-05 | 2022-08-09 | 78,740 | — | $0 | 402,997 | SEC↗ |
| SBTX Silverback Therapeutics, I | M Exercise | 2022-08-05 | 2022-08-09 | 78,740 | $1.27 | $100.0K | 254,242 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2022-05-27 | 2022-05-27 | 41,597 | — | $0 | 41,597 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-05-02 | 2022-05-04 | 136,214 | — | $0 | 136,214 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award | 2022-05-02 | 2022-05-04 | 68,107 | — | $0 | 175,502 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-02-01 | 2022-02-02 | 165,000 | — | $0 | 165,000 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-02-01 | 2022-02-02 | 104,500 | — | $0 | 104,500 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award | 2022-02-01 | 2022-02-02 | 27,500 | — | $0 | 107,395 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2021-06-13 | 2021-06-15 | 16,511 | — | $0 | 16,511 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2021-05-19 | 2021-05-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2020-12-03 | 2020-12-07 | 562,631 | — | $0 | 562,631 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 10,700 | — | $0 | 10,700 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 18,300 | — | $0 | 18,300 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 172,264 | $67.37 | $11.61M | 0 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 385,185 | $57.00 | $21.96M | 0 | SEC↗ |
| THOR Synthorx, Inc. | D To issuer deriv | 2020-01-23 | 2020-01-24 | 293,177 | $67.07 | $19.66M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 25,000 | $68.00 | $1.70M | 0 | SEC↗ |
| THOR Synthorx, Inc. | U Tender | 2020-01-23 | 2020-01-24 | 220,595 | $68.00 | $15.00M | 0 | SEC↗ |
| THOR Synthorx, Inc. | G Gift | 2020-01-08 | 2020-01-24 | 80,706 | — | $0 | 215,595 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise deriv | 2019-12-30 | 2020-01-02 | 12,912 | — | $0 | 0 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise deriv | 2019-12-30 | 2020-01-02 | 98,462 | — | $0 | 293,177 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise deriv | 2019-12-30 | 2020-01-02 | 147,264 | — | $0 | 172,264 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise deriv | 2019-12-30 | 2020-01-02 | 120,815 | — | $0 | 385,185 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise | 2019-12-30 | 2020-01-02 | 147,264 | $0.63 | $92.8K | 385,496 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise | 2019-12-30 | 2020-01-02 | 98,462 | $0.93 | $91.6K | 225,320 | SEC↗ |
| THOR Synthorx, Inc. | F Tax w/h | 2019-12-30 | 2020-01-02 | 210,010 | $70.63 | $14.83M | 296,301 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise | 2019-12-30 | 2020-01-02 | 120,815 | $11.00 | $1.33M | 506,311 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise | 2019-12-30 | 2020-01-02 | 12,912 | $0.93 | $12.0K | 238,232 | SEC↗ |
| THOR Synthorx, Inc. | A Award | 2019-12-18 | 2019-12-19 | 45,000 | — | $0 | 126,858 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise deriv | 2019-01-24 | 2019-01-25 | 25,000 | — | $0 | 319,528 | SEC↗ |
| THOR Synthorx, Inc. | M Exercise | 2019-01-24 | 2019-01-25 | 25,000 | $0.63 | $15.8K | 25,000 | SEC↗ |
| THOR Synthorx, Inc. | A Award deriv | 2018-12-06 | 2018-12-07 | 506,000 | — | $0 | 506,000 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 15,000 | $1.16 | $17.4K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | D To issuer deriv | 2014-02-03 | 2014-02-04 | 20,000 | $4.08 | $81.6K | 0 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award deriv | 2013-05-22 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRTX CORNERSTONE THERAPEUTICS I | A Award deriv | 2012-06-06 | 2012-06-08 | 20,000 | — | $0 | 20,000 | SEC↗ |